Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesGood Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report-Part V
Value in Health, 10/29/09
Mycka JM et al. – Understanding and accounting for all costs and consequences of the use of a medical treatment is in the best interests of all parties involved in the prescribing, consuming, reimbursement, selling, and manufacturing of bio/pharmaceuticals. Transparency, consistency, and clear communication of costs and value are essential for appropriate decision–making and should be important goals for all parties.
Related Articles
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations
Value in Health, 11/11/09
Relevance Score: 71%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report-Part III
Value in Health, 10/29/09
Relevance Score: 71%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09
Relevance Score: 71%
Value-Based Insurance Design in Medicare
Applied Health Economics and Health Policy, 10/20/09
Relevance Score: 70%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report-Part IV
Value in Health, 10/19/09
Relevance Score: 69%
Today in Billing and Collection...keeping you current
Receive free subspecialty "5-minute updates" via email
STANDARDS: EDI Accreditor Adopts 2010 Criteria
HealthDataManagement, 03/12/10
Credit Firm Buys EDI Vendor
HealthDataManagement, 03/12/10
HDM Puts Four in the Vespa Driving Seat
HealthDataManagement, 03/10/10
Today in Finance...keeping you current
Receive free subspecialty "5-minute updates" via email
Improving the health care experience by maximizing efficiency
Health Facilities Management, 03/16/10
Commission reports record increase in Medicaid enrollment
American Hospital Association News, 03/16/10
Cost-effectiveness of peridural and intravenous analgesic schemes
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 03/16/10
Today in Strategy and Ethics...keeping you current
Receive free subspecialty "5-minute updates" via email
Improving the health care experience by maximizing efficiency
Health Facilities Management, 03/16/10
Commission reports record increase in Medicaid enrollment
American Hospital Association News, 03/16/10
Nursing school admissions stall with recession, says survey
American Hospital Association News, 03/16/10
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
PharmacoEconomics, 03/16/10
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
European Journal of Clinical Pharmacology, 03/16/10
Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis
PharmacoEconomics, 03/15/10
Article Search
Sponsor